Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Drug susceptibility testing by dilution methods.

Jeannot K, Plésiat P.

Methods Mol Biol. 2014;1149:49-58. doi: 10.1007/978-1-4939-0473-0_6.

PMID:
24818896
[PubMed - in process]
2.

Antibiotic resistance determinants in a Pseudomonas putida strain isolated from a hospital.

Molina L, Udaondo Z, Duque E, Fernández M, Molina-Santiago C, Roca A, Porcel M, de la Torre J, Segura A, Plesiat P, Jeannot K, Ramos JL.

PLoS One. 2014 Jan 17;9(1):e81604. doi: 10.1371/journal.pone.0081604. eCollection 2014.

PMID:
24465371
[PubMed - in process]
Free PMC Article
3.

Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.

Guénard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K, Plésiat P.

Antimicrob Agents Chemother. 2014;58(1):221-8. doi: 10.1128/AAC.01252-13. Epub 2013 Oct 21. Erratum in: Antimicrob Agents Chemother. 2014 Mar;58(3):1833.

PMID:
24145539
[PubMed - in process]
Free PMC Article
4.

A convenient method to screen for carbapenemase-producing Pseudomonas aeruginosa.

Fournier D, Garnier P, Jeannot K, Mille A, Gomez AS, Plésiat P.

J Clin Microbiol. 2013 Nov;51(11):3846-8. doi: 10.1128/JCM.01299-13. Epub 2013 Aug 21.

PMID:
23966511
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Outbreak of metallo-β-lactamase VIM-2-positive strains of Pseudomonas aeruginosa in the Ivory Coast.

Jeannot K, Guessennd N, Fournier D, Müller E, Gbonon V, Plésiat P.

J Antimicrob Chemother. 2013 Dec;68(12):2952-4. doi: 10.1093/jac/dkt296. Epub 2013 Jul 25. No abstract available.

PMID:
23887865
[PubMed - indexed for MEDLINE]
6.

Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.

Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A; GERPA Study Group.

J Antimicrob Chemother. 2013 Aug;68(8):1763-71. doi: 10.1093/jac/dkt115. Epub 2013 Apr 29.

PMID:
23629014
[PubMed - indexed for MEDLINE]
Free Article
7.

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.

Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2013 Aug;68(8):1772-80. doi: 10.1093/jac/dkt098. Epub 2013 Apr 14.

PMID:
23587654
[PubMed - indexed for MEDLINE]
Free Article
8.

Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France.

Milan O, Debroize L, Bertrand X, Plesiat P, Valentin AS, Quentin R, Van der Mee-Marquet N.

Antimicrob Resist Infect Control. 2013 Apr 4;2(1):12. doi: 10.1186/2047-2994-2-12.

PMID:
23557539
[PubMed]
Free PMC Article
9.

Alternatives to carbapenems in ESBL-producing Escherichia coli infections.

Fournier D, Chirouze C, Leroy J, Cholley P, Talon D, Plésiat P, Bertrand X.

Med Mal Infect. 2013 Feb;43(2):62-6. doi: 10.1016/j.medmal.2013.01.006. Epub 2013 Feb 19.

PMID:
23433608
[PubMed - indexed for MEDLINE]
10.

Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.

Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plésiat P, Andremont A.

Antimicrob Agents Chemother. 2013 Mar;57(3):1488-95. doi: 10.1128/AAC.01823-12. Epub 2013 Jan 14.

PMID:
23318796
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Clonal dissemination of Pseudomonas aeruginosa isolates producing extended-spectrum β-lactamase SHV-2a.

Jeannot K, Fournier D, Müller E, Cholley P, Plésiat P.

J Clin Microbiol. 2013 Feb;51(2):673-5. doi: 10.1128/JCM.02313-12. Epub 2012 Dec 12.

PMID:
23241379
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprAB.

de Bentzmann S, Giraud C, Bernard CS, Calderon V, Ewald F, Plésiat P, Nguyen C, Grunwald D, Attree I, Jeannot K, Fauvarque MO, Bordi C.

PLoS Pathog. 2012;8(11):e1003052. doi: 10.1371/journal.ppat.1003052. Epub 2012 Nov 29. Erratum in: PLoS Pathog. 2012 Dec;8(12). doi: 10.1371/annotation/5c169544-7d19-40db-9a58-28b2fdf2c82c.

PMID:
23209420
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Spread of the bla(IMP-13) gene in French Pseudomonas aeruginosa through sequence types ST621, ST308 and ST111.

Fournier D, Jeannot K, Robert-Nicoud M, Muller E, Cholley P, van der Mee-Marquet N, Plésiat P.

Int J Antimicrob Agents. 2012 Dec;40(6):571-3. doi: 10.1016/j.ijantimicag.2012.08.006. Epub 2012 Oct 23. No abstract available.

PMID:
23089049
[PubMed - indexed for MEDLINE]
14.

Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting.

Hocquet D, Llanes C, Thouverez M, Kulasekara HD, Bertrand X, Plésiat P, Mazel D, Miller SI.

PLoS Pathog. 2012;8(6):e1002778. doi: 10.1371/journal.ppat.1002778. Epub 2012 Jun 14.

PMID:
22719259
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.

Buyck JM, Plésiat P, Traore H, Vanderbist F, Tulkens PM, Van Bambeke F.

Clin Infect Dis. 2012 Aug;55(4):534-42. doi: 10.1093/cid/cis473. Epub 2012 May 9.

PMID:
22573850
[PubMed - indexed for MEDLINE]
Free Article
16.

IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa.

Jeannot K, Poirel L, Robert-Nicoud M, Cholley P, Nordmann P, Plésiat P.

Antimicrob Agents Chemother. 2012 Apr;56(4):2187-90. doi: 10.1128/AAC.05838-11. Epub 2012 Jan 30.

PMID:
22290960
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.

Buyck JM, Guénard S, Plésiat P, Tulkens PM, Van Bambeke F.

J Antimicrob Chemother. 2012 Mar;67(3):771-5. doi: 10.1093/jac/dkr543. Epub 2012 Jan 3. No abstract available.

PMID:
22218683
[PubMed - indexed for MEDLINE]
Free Article
18.

Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis.

Naudin C, Joulin-Giet A, Couetdic G, Plésiat P, Szymanska A, Gorna E, Gauthier F, Kasprzykowski F, Lecaille F, Lalmanach G.

PLoS One. 2011;6(9):e25577. doi: 10.1371/journal.pone.0025577. Epub 2011 Sep 28.

PMID:
21980493
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin.

Llanes C, Köhler T, Patry I, Dehecq B, van Delden C, Plésiat P.

Antimicrob Agents Chemother. 2011 Dec;55(12):5676-84. doi: 10.1128/AAC.00101-11. Epub 2011 Sep 12.

PMID:
21911574
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.

Hocquet D, Colomb M, Dehecq B, Belmonte O, Courvalin P, Plésiat P, Meziane-Cherif D.

J Antimicrob Chemother. 2011 Aug;66(8):1745-50. doi: 10.1093/jac/dkr187. Epub 2011 Jun 10.

PMID:
21665906
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk